Advertisement
U.S. markets closed

Pacific Biosciences of California, Inc. (PACB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
1.7200+0.1500 (+9.55%)
At close: 04:00PM EST
1.7200 0.00 (0.00%)
After hours: 07:39PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
173,147
200,521
128,304
130,513
78,893
Cost of Revenue
136,352
147,741
79,269
71,653
46,327
Gross Profit
36,795
52,780
49,035
58,860
32,566
Operating Expense
350,165
363,145
353,854
237,023
136,951
Operating Income
-313,370
-310,365
-304,819
-178,163
-104,385
Net Non Operating Interest Income Expense
-14,226
-14,343
-14,690
-12,530
-267
Other Income Expense
-67,362
6,549
5,261
-84,179
134,055
Pretax Income
-394,958
-318,159
-314,248
-274,872
29,403
Tax Provision
-718
-11,424
0
-93,649
0
Net Income Common Stockholders
-394,240
-306,735
-314,248
-181,223
29,403
Diluted NI Available to Com Stockholders
-394,240
-306,735
-314,248
-181,223
29,403
Basic EPS
-1.27
-1.21
-1.40
-0.89
0.18
Diluted EPS
-1.27
-1.21
-1.40
-0.89
0.17
Basic Average Shares
243,376
253,629
224,550
204,136
165,187
Diluted Average Shares
243,376
253,629
224,550
204,136
174,970
Total Operating Income as Reported
-408,833
-334,467
-307,196
-210,435
-104,385
Total Expenses
486,517
510,886
433,123
308,676
183,278
Net Income from Continuing & Discontinued Operation
-394,240
-306,735
-314,248
-181,223
29,403
Normalized Income
-298,951
-281,541
-311,871
-125,603
-102,597
Interest Expense
14,226
14,343
14,690
12,530
267
Net Interest Income
-14,226
-14,343
-14,690
-12,530
-267
EBIT
-380,732
-303,816
-299,558
-262,342
29,670
EBITDA
-326,631
-277,282
-282,240
-250,757
38,974
Reconciled Cost of Revenue
101,044
127,364
61,951
60,068
46,327
Reconciled Depreciation
54,101
26,534
17,318
11,585
9,304
Net Income from Continuing Operation Net Minority Interest
-394,240
-306,735
-314,248
-181,223
29,403
Total Unusual Items Excluding Goodwill
-95,463
-26,135
-2,377
-84,272
132,000
Total Unusual Items
-95,463
-26,135
-2,377
-84,272
132,000
Normalized EBITDA
-231,168
-251,147
-279,863
-166,485
-93,026
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-173.5436
-940.86
0
-28,652
0